BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7384181)

  • 21. [Drug permeation through synthetic lipoid membranes. 7. A resorption model with a lecithin membrane for testing the biological availability of drugs].
    Falk M; Fürst W; Lauterbach H
    Pharmazie; 1975 Dec; 30(12):775-9. PubMed ID: 3807
    [No Abstract]   [Full Text] [Related]  

  • 22. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
    Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
    Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of oral drug absorption in humans by theoretical passive absorption model.
    Obata K; Sugano K; Saitoh R; Higashida A; Nabuchi Y; Machida M; Aso Y
    Int J Pharm; 2005 Apr; 293(1-2):183-92. PubMed ID: 15778056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Permeability through DOPC/dodecane membranes: measurement and LFER modelling.
    Huque FT; Box K; Platts JA; Comer J
    Eur J Pharm Sci; 2004 Nov; 23(3):223-32. PubMed ID: 15489123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fast monolithic micellar liquid chromatography: an alternative drug permeability assessing method for high-throughput screening.
    Detroyer A; Stokbroekx S; Bohets H; Lorreyne W; Timmerman P; Verboven P; Massart DL; Vander Heyden Y
    Anal Chem; 2004 Dec; 76(24):7304-9. PubMed ID: 15595873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro permeation of repellent DEET and sunscreen oxybenzone across three artificial membranes.
    Wang T; Kasichayanula S; Gu X
    Int J Pharm; 2006 Mar; 310(1-2):110-7. PubMed ID: 16414221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permeability of model stratum corneum lipid membrane measured using quartz crystal microbalance.
    Lee D; Ashcraft JN; Verploegen E; Pashkovski E; Weitz DA
    Langmuir; 2009 May; 25(10):5762-6. PubMed ID: 19435292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of an artificial membrane for determination of drug availability.
    Loftsson T; Konrádsdóttir F; Másson M
    Int J Pharm; 2006 Dec; 326(1-2):60-8. PubMed ID: 16920289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in parallel artificial membrane permeability assay and its applications].
    Wu YF; Liu H; Ni JM
    Yao Xue Xue Bao; 2011 Aug; 46(8):890-5. PubMed ID: 22007511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Halogenation of drugs enhances membrane binding and permeation.
    Gerebtzoff G; Li-Blatter X; Fischer H; Frentzel A; Seelig A
    Chembiochem; 2004 May; 5(5):676-84. PubMed ID: 15122640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug permeation through artificial lipoid membranes. 20. The effectiveness of multiple-lamellar liposomes for evaluating drug transport].
    Neubert R; Fürst W; Wurschi B
    Pharmazie; 1987 Feb; 42(2):102-3. PubMed ID: 3602045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug permeation through synthetic lipid membranes. 5. Permeability of synthetic lecithin membranes for a group of structurally similar heterocyclics].
    Falk M; Fürst W; Hannig E; Böhm R
    Pharmazie; 1974 Aug; 29(8):542-3. PubMed ID: 4409279
    [No Abstract]   [Full Text] [Related]  

  • 35. Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.
    Fang JY; Hung CF; Chi CH; Chen CC
    Int J Pharm; 2009 Oct; 380(1-2):33-9. PubMed ID: 19563870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the role of different drug transport routes in permeability screening.
    Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
    J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of an in vitro method for prediction of human drug absorption I. Assessment of artificial membrane composition.
    Corti G; Maestrelli F; Cirri M; Furlanetto S; Mura P
    Eur J Pharm Sci; 2006 Mar; 27(4):346-53. PubMed ID: 16359848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug permeation through synthetic lipoid membranes. 8. Mathematical description of substance transport with constant concentration in compartment A].
    Fürst W; Falk M; Neubert R; Wiessner U; Klapper I
    Pharmazie; 1976 Aug; 31(8):557-9. PubMed ID: 11511
    [No Abstract]   [Full Text] [Related]  

  • 39. [Molecular model of surface-active substances-biomembrane interactions. Effects on drug transport].
    Alhaique F; Marchetti M; Riccieri FM; Santucci E
    Boll Chim Farm; 1973 Mar; 112(3):170-6. PubMed ID: 4721641
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug permeation through membranes. I. Effect of various substances on amobarbital permeation through polydimethylsiloxane.
    Lovering EG; Black DB
    J Pharm Sci; 1973 Apr; 62(4):602-6. PubMed ID: 4698980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.